These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 29779930)
21. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response. Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622 [TBL] [Abstract][Full Text] [Related]
22. Influenza A virus entry inhibitors targeting the hemagglutinin. Yang J; Li M; Shen X; Liu S Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380 [TBL] [Abstract][Full Text] [Related]
23. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells. Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117 [TBL] [Abstract][Full Text] [Related]
24. The G Protein-Coupled Receptor FFAR2 Promotes Internalization during Influenza A Virus Entry. Wang G; Jiang L; Wang J; Zhang J; Kong F; Li Q; Yan Y; Huang S; Zhao Y; Liang L; Li J; Sun N; Hu Y; Shi W; Deng G; Chen P; Liu L; Zeng X; Tian G; Bu Z; Chen H; Li C J Virol; 2020 Jan; 94(2):. PubMed ID: 31694949 [TBL] [Abstract][Full Text] [Related]
25. The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus. Ng WC; Londrigan SL; Nasr N; Cunningham AL; Turville S; Brooks AG; Reading PC J Virol; 2016 Jan; 90(1):206-21. PubMed ID: 26468543 [TBL] [Abstract][Full Text] [Related]
26. A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin. Yu F; Song H; Wu Y; Chang SY; Wang L; Li W; Hong B; Xia S; Wang C; Khurana S; Feng Y; Wang Y; Sun Z; He B; Hou D; Manischewitz J; King LR; Song Y; Min JY; Golding H; Ji X; Lu L; Jiang S; Dimitrov DS; Ying T Cell Host Microbe; 2017 Oct; 22(4):471-483.e5. PubMed ID: 28966056 [TBL] [Abstract][Full Text] [Related]
27. The role of fusion activity of influenza A viruses in their biological properties. Jakubcová L; Hollý J; Varečková E Acta Virol; 2016 Jun; 60(2):121-35. PubMed ID: 27265461 [TBL] [Abstract][Full Text] [Related]
28. Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics. Winarski KL; Tang J; Klenow L; Lee J; Coyle EM; Manischewitz J; Turner HL; Takeda K; Ward AB; Golding H; Khurana S Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15194-15199. PubMed ID: 31296560 [TBL] [Abstract][Full Text] [Related]
30. The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus. Rahman SK; Ansari MA; Gaur P; Ahmad I; Chakravarty C; Verma DK; Sharma A; Chhibber S; Nehal N; Wirth D; Lal SK Viruses; 2021 Apr; 13(5):. PubMed ID: 33919410 [TBL] [Abstract][Full Text] [Related]
31. Live Visualization of Hemagglutinin Dynamics During Infection by Using a Novel Reporter Influenza A Virus. Dos Anjos Borges LG; Pisanelli G; Khatun O; García-Sastre A; Tripathi S Viruses; 2020 Jun; 12(6):. PubMed ID: 32604762 [TBL] [Abstract][Full Text] [Related]
32. IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization. Lanz C; Schotsaert M; Magnus C; Karakus U; Hunziker A; Sempere Borau M; Martínez-Romero C; Spieler EE; Günther SC; Moritz E; Hale BG; Trkola A; García-Sastre A; Stertz S J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33882122 [TBL] [Abstract][Full Text] [Related]
33. Exploiting the Affimer platform against influenza A virus. Debski-Antoniak O; Flynn A; Klebl DP; Rojas Rechy MH; Tiede C; Wilson IA; Muench SP; Tomlinson D; Fontana J mBio; 2024 Aug; 15(8):e0180424. PubMed ID: 39037231 [TBL] [Abstract][Full Text] [Related]
34. Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function. Marvin SA; Russier M; Huerta CT; Russell CJ; Schultz-Cherry S J Virol; 2017 Jan; 91(2):. PubMed ID: 27807237 [TBL] [Abstract][Full Text] [Related]
35. Cell type- and replication stage-specific influenza virus responses in vivo. Fay EJ; Aron SL; Macchietto MG; Markman MW; Esser-Nobis K; Gale M; Shen S; Langlois RA PLoS Pathog; 2020 Aug; 16(8):e1008760. PubMed ID: 32790753 [TBL] [Abstract][Full Text] [Related]
36. Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells. Rodriguez-Frandsen A; Martin-Sancho L; Gounder AP; Chang MW; Liu WC; De Jesus PD; von Recum-Knepper J; Dutra MS; Huffmaster NJ; Chavarria M; Mena I; Riva L; Nguyen CB; Dobariya S; Herbert KM; Benner C; Albrecht RA; García-Sastre A; Chanda SK J Virol; 2020 Jan; 94(4):. PubMed ID: 31776276 [TBL] [Abstract][Full Text] [Related]
37. Bik Mediates Caspase-Dependent Cleavage of Viral Proteins to Promote Influenza A Virus Infection. Mebratu YA; Tipper J; Chand HS; Walton S; Harrod KS; Tesfaigzi Y Am J Respir Cell Mol Biol; 2016 May; 54(5):664-73. PubMed ID: 26437021 [TBL] [Abstract][Full Text] [Related]
38. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs. Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532 [TBL] [Abstract][Full Text] [Related]
39. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1. Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772 [TBL] [Abstract][Full Text] [Related]
40. Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry. Du R; Cui Q; Rong L Viruses; 2019 May; 11(5):. PubMed ID: 31137516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]